Testimonials Lead To Overbroad Claims, DDMAC Warning Letter Says

Implied efficacy claims from a physician and patients for Testopel testosterone pellets, among many other problems with a series of promotional pieces, draw a warning letter to Slate Pharmaceuticals.

More from Archive

More from Pink Sheet